Renishaw Neuro Solutions enables direct-to-target delivery for a broad range of applications. Using the neuroinfuse™ drug delivery system, predictable and translatable gene therapy infusions in preclinical and clinical trials can become a reality.

Our Lab2Clinic™ service supports pharma through the preclinical journey, translation into clinical trials and scaled-up commercialisation. We have a wide geographical reach and we focus on promoting long-term partnerships.

All this is underpinned by our FDA-cleared, CE-marked stereotactic products borne out of a +45-year precision engineering heritage.

Team Members

Ed Littlewood

Ed Littlewood

Marketing Manager

Stuart Campbell 02

Stuart Campbell

Clinical Sales Development Manager